JUN 20, 2018 7:00 AM EDT

Utilizing Same-Day Sepsis Pathogen ID for Faster Therapy, Enhanced Stewardship, Improved Outcomes

Sponsored by: T2 Biosystems, Inc.
Speaker
  • Associate Professor of Medicine, Infectious Diseases Division and Director, Mycology Program, University of Pittsburgh
    Biography
      Dr. Clancy is the Associate Professor of Medicine in the Infectious Diseases Division and the Director of the Mycology Program at the University of Pittsburgh. Dr. Clancy is widely published and a respected scientific expert on novel diagnostics. He is a leading researcher on antimicrobial resistance in bacteria and fungi and their clinical relevance.

    Abstract

    DATE: June 20, 2018
    TIME: 07:00AM PDT, 10:00AM EDT

    Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes and cost. One of the major hurdles to effective sepsis management is the limitations of conventional diagnostics, which are blood-culture based and take 1 to 5 or more days to identify sepsis-causing pathogens. Blood culture also misses 35-50% of infections altogether on first blood draw and can be greatly affected by the presence of antimicrobials. These delays impact patient outcomes as one hour of delayed treatment increases mortality risk by nearly 8%.

    To advance sepsis care, hospitals are turning to new technology that does not rely on blood culture. This year, six new peer reviewed studies have been published on T2Dx diagnostics, which provide blood culture independent sepsis pathogen ID results in 3 to 5 hours. Due to improved detection, these studies from the U.S. and EU demonstrate that clinicians can achieve faster targeted therapy, better outcomes, enhanced stewardship, and reduced cost of care. The T2Dx Instrument runs the first FDA-cleared tests to identify deadly sepsis-causing pathogens in whole blood: the T2Candida Panel and the now FDA-Cleared T2Bacteria Panel.

    In this webinar you will:

    • Review the latest clinical data on the accuracy and impact of blood culture independent diagnostics
    • Demonstrate the potential for new diagnostics to improve outcomes for patients suspected of sepsis while improving stewardship
    • Understand opportunities and barriers to implementation of blood culture independent diagnostics into routine clinical care and sepsis management protocols

    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more